Open Label, Phase I ZD6474 Head and Neck Cancer Study

Completed · Phase 1

Conditions studied: Head and Neck Cancer

In brief

The purpose of this study is to determine the maximum tolerated dose of ZD6474 given in combination with radiation or in combination with chemotherapy and radiation in patients with squamous cell carcinoma of the head and neck.

Key facts

Study ID

NCT00450138

Run by

Sanofi

People needed

48

Starts

2006-12-01

Expected to finish

2011-11-01

Last updated by the study team

2016-08-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stage III-IV squamous cell carcinoma of the head and neck

You may not qualify if…

• No previous treatment for head and neck cancer, adequate cardiac function

Where it is running

• Research Site — Denver, Colorado, United States
• Research Site — Chicago, Illinois, United States
• Research Site — Dallas, Texas, United States
• Research Site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.